Actuate Therapeutics logo

Actuate Therapeutics Share Price (NASDAQ: ACTU)

$8.46

0.24

(2.92%)

Last updated on

Check the interactive Actuate Therapeutics Stock chart to analyse performance

Actuate Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$8.41
    Today's High:$8.46

    Day's Volatility :0.65%

  • 52 Weeks Low:$5.47
    52 Weeks High:$11.99

    52 Weeks Volatility :54.38%

Actuate Therapeutics Stock Returns

PeriodActuate TherapeuticsIndex (Russel 2000)
3 Months
-19.92%
0.0%
6 Months
30.26%
0.0%
1 Year
5.87%
0.0%
3 Years
-1.51%
-4.7%

Actuate Therapeutics Key Stats

Check Actuate Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$8.22
Open
$8.405
Today's High
$8.46
Today's Low
$8.405
Market Capitalization
$170.5M
Today's Volume
$41.1K
52 Week High
$11.99
52 Week Low
$5.47
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-3.11
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

Stock Returns calculator for Actuate Therapeutics Stock including INR - Dollar returns

The Actuate Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Actuate Therapeutics investment value today

Current value as on today

₹1,10,377

Returns

₹10,377

(+10.38%)

Returns from Actuate Therapeutics Stock

₹5,093 (+5.09%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Actuate Therapeutics Stock

-63%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Actuate Therapeutics Stock from India on INDmoney has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Actuate Therapeutics Stock

Rating
Trend

Actuate Therapeutics Share Price Target

What analysts predicted

Upside of 216.19%

Target:

$26.75

Current:

$8.46

Actuate Therapeutics share price target is $26.75, a slight Upside of 216.19% compared to current price of $8.46 as per analysts' prediction.

Actuate Therapeutics Stock Insights

  • Price Movement

    In the last 3 months, ACTU stock has moved down by -28.7%
  • ACTU vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 64.6%

Actuate Therapeutics Technicals Summary

Sell

Neutral

Buy

Actuate Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Actuate Therapeutics Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Actuate Therapeutics logo
16.97%
30.26%
5.87%
-1.51%
-1.51%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Actuate Therapeutics

Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States. The company's lead product candidate is elraglusib injection, a glycogen synthase kinase-3 inhibitor that is in Phase 2 trial to treat metastatic pancreatic ductal adenocarcinoma. It also develops elraglusib, which is in Phase 1/2 trial for the treatment of refractory pediatric malignancies, including Ewing sarcoma, as well as metastatic melanoma and colorectal cancer. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. Actuate Therapeutics, Inc. was incorporated in 2015 and is headquartered in Fort Worth, Texas.
Organization
Actuate Therapeutics
Employees
10
CEO
Mr. Daniel M. Schmitt
Industry
Miscellaneous

Key Management of Actuate Therapeutics

NameTitle
Mr. Daniel M. Schmitt
CEO, President & Director
Dr. Andrew P. Mazar Ph.D.
Co-Founder & COO
Mr. Paul J. Lytle CPA
Chief Financial Officer
Dr. Alan Kozikowski Ph.D.
Scientific Founder and Advisor

Important FAQs about investing in ACTU Stock from India :

What is Actuate Therapeutics share price today?

Actuate Therapeutics share price today is $8.46 as on at the close of the market. Actuate Therapeutics share today touched a day high of $8.46 and a low of $8.41.

What is the 52 week high and 52 week low for Actuate Therapeutics share?

Actuate Therapeutics share touched a 52 week high of $11.99 and a 52 week low of $5.47. Actuate Therapeutics stock price today i.e. is closed at $8.46, lower by 29.44% versus the 52 week high.

How to invest in Actuate Therapeutics Stock (ACTU) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Actuate Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Actuate Therapeutics Shares that will get you 0.1773 shares as per Actuate Therapeutics share price of $8.46 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Actuate Therapeutics Stock (ACTU) from India?

Indian investors can start investing in Actuate Therapeutics (ACTU) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Actuate Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Actuate Therapeutics share’s latest price of $8.46 as on August 30, 2025 at 1:29 am IST, you will get 1.1820 shares of Actuate Therapeutics. Learn more about fractional shares .

What are the returns that Actuate Therapeutics has given to Indian investors in the last 5 years?

Actuate Therapeutics stock has given -1.51% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?